Jason Lettmann
Chief Executive Officer
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alx Oncology Holdings Inc (ALXO) | Chief Executive Officer | $724,500 | $2,470,844 |
| 2024 | Alx Oncology Holdings Inc (ALXO) | Chief Executive Officer | $700,000 | $6,640,830 |
| 2023 | Alx Oncology Holdings Inc (ALXO) | Chief Executive Officer | $217,330 | $4,857,183 |
| 2022 | Alx Oncology Holdings Inc (ALXO) | Chief Executive Officer | — | — |
Executive changes
Earnings-call appearances
-
Jefferies Global Healthcare Conference in New York2026-06-03
Alx Oncology Holdings Inc (ALXO)
-
Alx Oncology Holdings Inc Q1 FY2026 Earnings Call2026-05-08
Alx Oncology Holdings Inc (ALXO)
-
Alx Oncology Holdings Inc Q4 FY2025 Earnings Call2026-02-27
Alx Oncology Holdings Inc (ALXO)
-
Alx Oncology Holdings Inc Q3 FY2025 Earnings Call2025-11-07
Alx Oncology Holdings Inc (ALXO)
-
Alx Oncology Holdings Inc Q2 FY2025 Earnings Call2025-08-12
Alx Oncology Holdings Inc (ALXO)